Primary Small Bowel Adenomas and Adenocarcinomas-recent Advances
Overview
Molecular Biology
Pathology
Authors
Affiliations
The small intestine represents 75% of the length and 90% of the absorptive surface area of the gastrointestinal tract (GIT), yet only 2% of digestive system cancers occur at this site. Adenocarcinoma accounts for half of small bowel malignancies. There have been a number of important recent advances in our understanding, classification and treatment of small bowel tumours. Over recent years, ampullary tumours have become recognised as a form of small bowel carcinoma, distinct from head of pancreas and lower biliary tract tumours. This is reflected in separate TNM systems and increasing interest in separating intestinal from pancreatobiliary subtypes. The recognition of the importance of microsatellite (MSI) status and the advent of molecular pathology has also changed our approach to these neoplasms.
Abdulqader G Open Med (Wars). 2024; 19(1):20241022.
PMID: 39247437 PMC: 11377978. DOI: 10.1515/med-2024-1022.
Immune signature of small bowel adenocarcinoma and the role of tumor microenvironment.
Christodoulidis G, Kouliou M, Koumarelas K World J Gastroenterol. 2024; 30(8):794-798.
PMID: 38516246 PMC: 10950647. DOI: 10.3748/wjg.v30.i8.794.
Pierro A, Minordi L, Larosa L, Cipri C, Guerri G, Quinto F Life (Basel). 2023; 13(9).
PMID: 37763240 PMC: 10532809. DOI: 10.3390/life13091836.
Bile acids as carcinogens in the colon and at other sites in the gastrointestinal system.
Bernstein H, Bernstein C Exp Biol Med (Maywood). 2022; 248(1):79-89.
PMID: 36408538 PMC: 9989147. DOI: 10.1177/15353702221131858.
Epidemiology, Risk Factors and Diagnosis of Small Bowel Adenocarcinoma.
Aparicio T, Pachev A, Laurent-Puig P, Svrcek M Cancers (Basel). 2022; 14(9).
PMID: 35565398 PMC: 9103761. DOI: 10.3390/cancers14092268.